Real Estate Investment Trust (Office & Life Science)
Strategic Profile
As a publicly traded REIT and S&P MidCap 400 member, Kilroy differentiates itself through a focus on sustainable, modern business environments designed for technology, media, and life science companies. The company combines its development expertise with a significant redevelopment pipeline, including a $1.2 billion development project representing approximately 872,000 square feet of space, positioning it as a growth-oriented West Coast real estate platform.
Cyborg Score Rationale
Kilroy maintains a stable portfolio with solid occupancy metrics and strong geographic positioning in high-demand West Coast markets. However, the REIT sector faces headwinds from elevated office vacancy rates and market uncertainty, though the company's life science focus and development pipeline provide growth opportunities.
Top Insights
Strong life science and office portfolio diversification across premium West Coast markets with 16.8M sq ft as of Q3 2025
Significant development pipeline of $1.2B+ with 872,000 sq ft in tenant improvement phase demonstrates growth trajectory
Award-winning sustainability leadership with tenth consecutive ENERGY STAR Partner of the Year recognition from EPA
Portfolio occupancy of 81.6% with 83.8% lease rate reflects solid market positioning despite office sector headwinds
Named Competitors
Hudson Pacific Properties — West Coast office and life science REIT
Douglas Emmett — Office and multifamily REIT in Southern California
Highwoods Properties — Office REIT with mixed-use portfolio
Recent Developments
(Feb 2026) ISS Governance QualityScore of 4 with balanced governance profile
(Sep 2025) Portfolio increased to 16.8M sq ft with 81.6% occupancy and 83.8% lease rate
(2024) Achieved eighth consecutive ENERGY STAR Sustained Excellence designation
Open the full interactive Kilroy Realty Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.